GL1X · GenesisL1 explorer

Research workbench

Crystal structure of RV3378C with inhibitor bph-629

Analyse Crystal structure of RV3378C with inhibitor bph-629 in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
3WQM
Type
protein
Length
294 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Diterpene synthase
EC
3.1.7.9, 3.1.7.8
UniProt
O50407
Ligands
B29, MG, PO4
Pockets
2 · best druggability 0.74

Structure

x-ray diffraction · 1 distinct chain · 51% helix, 14% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ADiterpene synthase (EC 3.1.7.9, 3.1.7.8)protein29451% helix, 14% strandO50407

Ligands and binding sites

  • B29 · [2-(3-dibenzofuran-4-yl-phenyl)-1-hydroxy-1-phosphono-ethyl]-phosphonic acid · ligand · 2 copies · chains A
  • MG · Magnesium ion · metal · chains A
  • PO4 · Phosphate ion · ion · 2 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
15030.740.8253B29, MG
21250.430.7625empty

Compared structures

  • 3WQM · Crystal structure of Rv3378c with inhibitor BPH-629 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.